| 摘要 |
The present invention relates to the use of antibiotics with specific therapeutic activities combined with the simultaneous use of lactobacilli and/or bifidobacteria having a non-transferable antibiotic resistance and with the same therapeutic indication as said antibiotics. In particular, the present invention relates to a composition comprising or, alternatively, consisting of antibiotics suitable for the treatment of acute and chronic intestinal infections due to gram-positive and gram-negative bacteria; diarrheic syndromes; diarrhea due to an imbalance of the intestinal microflora such as for example, summer diarrhea, traveler's diarrhea and enterocolitis; pre- and postoperative prophylaxis of infectious complications in gastrointestinal surgery; gastrointestinal diseases such as irritable bowel syndrome (IBS), constipation, alterations of intestinal microflora; chronic inflammatory intestinal diseases (IBD) and inflammations due to Helicobacter pylori; said antibiotics belonging to the rifamycin family, preferably rifaximin, being combined with specific strains of bacteria belonging to the species Bifidobacterium longum having the same therapeutic indication as said antibiotics. |
